Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy. - Wikidata - wikimedia - TriplyDB

Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy.

Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy.

http://www.wikidata.org/entity/Q37841572

about

Anti-thrombotic effects of α-linolenic acid isolated from Zanthoxylum bungeanum Maxim seeds.Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy Novel agents for anti-platelet therapy.Rap2B GTPase: structure, functions, and regulation.Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research.Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives.Patient Evaluation and Preparation in Vascular and Interventional Radiology: What Every Interventional Radiologist Should Know (Part 2: Patient Preparation and Medications).Roles of Mac-1 and glycoprotein IIb/IIIa integrins in leukocyte-platelet aggregate formation: stabilization by Mac-1 and inhibition by GpIIb/IIIa blockers.

P2860

Q35274877-AE06E239-2418-4544-996D-3E59346C9797 Q35508318-C6052FAC-4A95-4594-A68B-B77208267DE5 Q35574825-6A7EC859-D985-4889-B3EE-292565BE98EA Q35969641-B3FF0C31-323A-4510-9466-9C5B762D21D7 Q37670794-93547DBA-F626-4E10-AFBD-F158E9850CDB Q38018679-EA2860FE-DA9E-4E1B-9519-A31C3E3383AA Q38647607-EB504204-3F5B-4F9E-AE83-9F38CBE52659 Q51758607-373DFBB9-9768-49FF-B9FB-ABA55A22C59F

P2860

Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy.

http://www.wikidata.org/entity/Q37841572

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Glycoprotein IIb/IIIa inhibito ...... assess antiplatelet efficacy.

@en

Glycoprotein IIb/IIIa inhibito ...... assess antiplatelet efficacy.

@nl

type

label

Glycoprotein IIb/IIIa inhibito ...... assess antiplatelet efficacy.

@en

Glycoprotein IIb/IIIa inhibito ...... assess antiplatelet efficacy.

@nl

prefLabel

Glycoprotein IIb/IIIa inhibito ...... assess antiplatelet efficacy.

@en

Glycoprotein IIb/IIIa inhibito ...... assess antiplatelet efficacy.

@nl

P1433

Q37841572-5110F9F8-A036-4CA1-AFA1-A79B31F08012

P1476

Q37841572-288AD123-5B93-40E4-90AE-522FEE00976E

P2093

Q37841572-05CD7F20-0EFB-4C88-9C62-943B9506998E

P2860

Q37841572-05249F02-8BE5-4309-86F9-D834E2B9961E

Q37841572-057FC165-5648-494A-AE12-A676BFEF77DD

Q37841572-0B44916E-A22B-451D-8565-1DAE0AFB183E

Q37841572-13CFF831-88CD-422D-AD03-0459B67ADF7D

Q37841572-187C39A6-50CD-4976-B19A-5C93BE3DC54C

Q37841572-1A7C2917-3158-49F3-AA5C-957BDD824F2A

Q37841572-20F1888A-4EE7-45CE-B452-D6424F0F3EE6

Q37841572-2152C109-0F78-4F84-A328-221F05B990E5

Q37841572-29EFDF13-12FE-4442-890A-DF56A1C81260

Q37841572-3984D539-4AEA-414B-B44D-4EF68BC0B94A

P304

Q37841572-E26B300A-1E4A-4F79-9959-23209F94FAC5

P31

Q37841572-DC5D84FA-877F-448E-B868-7AE968078948

P356

Q37841572-7362A3EE-F383-4BAA-9AC3-921AF0399D5D

P433

Q37841572-67F61718-9677-4BED-A68F-69EE4B9436A1

P478

Q37841572-A93C9DF6-7DB2-41EC-826C-5B0AAA41F6EB

P50

Q37841572-0F862052-3222-4899-A652-012C8B1BD2A1

Q37841572-2CB70FFB-7B3F-450A-B9D2-A038693C7CC1

Q37841572-5E6755CC-2470-41CE-AC66-F0FA424916B6

Q37841572-BEE9E18D-81A5-4B4F-8835-A446DB652761

P577

Q37841572-DAA1BB62-7818-4094-8B20-B08E3E375715

P5875

Q37841572-A4E19F4C-99D1-4922-A83D-57C48CC1609E

P698

Q37841572-4B1101BD-E6FC-4BF2-9767-45A3B77096A4

P356

P1433

Biomarkers in Medicine

P1476

Glycoprotein IIb/IIIa inhibito ...... assess antiplatelet efficacy.

@en

P2093

Elisa Danese

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of an integrin IIb 3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation

Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials

Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

Platelet function tests and flow cytometry to monitor antiplatelet therapy

Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents

Determination of platelet aggregation inhibition during percutaneous coronary intervention with the platelet function analyzer PFA-100

Genetic and acquired determinants of individual variability of response to antiplatelet drugs

P304

63-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/BMM.10.119

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Martina Montagnana

Emmanuel J Favaloro

Massimo Franchini

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49835003

http://www.w3.org/2001/XMLSchema#string

P698

21319966

http://www.w3.org/2001/XMLSchema#string